370 related articles for article (PubMed ID: 36185202)
1. Mitochondrial metabolic determinants of multiple myeloma growth, survival, and therapy efficacy.
Nair R; Gupta P; Shanmugam M
Front Oncol; 2022; 12():1000106. PubMed ID: 36185202
[TBL] [Abstract][Full Text] [Related]
2. Revisiting the Warburg effect: historical dogma versus current understanding.
Vaupel P; Multhoff G
J Physiol; 2021 Mar; 599(6):1745-1757. PubMed ID: 33347611
[TBL] [Abstract][Full Text] [Related]
3. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.
Lu J; Tan M; Cai Q
Cancer Lett; 2015 Jan; 356(2 Pt A):156-64. PubMed ID: 24732809
[TBL] [Abstract][Full Text] [Related]
4. Warburg and Beyond: The Power of Mitochondrial Metabolism to Collaborate or Replace Fermentative Glycolysis in Cancer.
Cassim S; Vučetić M; Ždralević M; Pouyssegur J
Cancers (Basel); 2020 Apr; 12(5):. PubMed ID: 32365833
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial metabolism-mediated redox regulation in cancer progression.
Boese AC; Kang S
Redox Biol; 2021 Jun; 42():101870. PubMed ID: 33509708
[TBL] [Abstract][Full Text] [Related]
6. Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden.
Prinz C; Vasyutina E; Lohmann G; Schrader A; Romanski S; Hirschhäuser C; Mayer P; Frias C; Herling CD; Hallek M; Schmalz HG; Prokop A; Mougiakakos D; Herling M
Mol Cancer; 2015 Jun; 14():114. PubMed ID: 26041471
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An Overview.
Barbato A; Scandura G; Puglisi F; Cambria D; La Spina E; Palumbo GA; Lazzarino G; Tibullo D; Di Raimondo F; Giallongo C; Romano A
Front Oncol; 2020; 10():604143. PubMed ID: 33409153
[TBL] [Abstract][Full Text] [Related]
8. Homeostasis of redox status derived from glucose metabolic pathway could be the key to understanding the Warburg effect.
Zhang S; Yang C; Yang Z; Zhang D; Ma X; Mills G; Liu Z
Am J Cancer Res; 2015; 5(4):1265-80. PubMed ID: 26101696
[TBL] [Abstract][Full Text] [Related]
9. Homeostasis of redox status derived from glucose metabolic pathway could be the key to understanding the Warburg effect.
Zhang S; Yang C; Yang Z; Zhang D; Ma X; Mills G; Liu Z
Am J Cancer Res; 2015; 5(3):928-44. PubMed ID: 26045978
[TBL] [Abstract][Full Text] [Related]
10. Queuine Micronutrient Deficiency Promotes Warburg Metabolism and Reversal of the Mitochondrial ATP Synthase in Hela Cells.
Hayes P; Fergus C; Ghanim M; Cirzi C; Burtnyak L; McGrenaghan CJ; Tuorto F; Nolan DP; Kelly VP
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32213952
[TBL] [Abstract][Full Text] [Related]
11. Tumor cells switch to mitochondrial oxidative phosphorylation under radiation via mTOR-mediated hexokinase II inhibition--a Warburg-reversing effect.
Lu CL; Qin L; Liu HC; Candas D; Fan M; Li JJ
PLoS One; 2015; 10(3):e0121046. PubMed ID: 25807077
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Reprogramming and Redox Signaling in Pulmonary Hypertension.
Plecitá-Hlavatá L; D'alessandro A; El Kasmi K; Li M; Zhang H; Ježek P; Stenmark KR
Adv Exp Med Biol; 2017; 967():241-260. PubMed ID: 29047090
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria Targeting as an Effective Strategy for Cancer Therapy.
Ghosh P; Vidal C; Dey S; Zhang L
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397535
[TBL] [Abstract][Full Text] [Related]
14. Elucidating the Metabolic Plasticity of Cancer: Mitochondrial Reprogramming and Hybrid Metabolic States.
Jia D; Park JH; Jung KH; Levine H; Kaipparettu BA
Cells; 2018 Mar; 7(3):. PubMed ID: 29534029
[TBL] [Abstract][Full Text] [Related]
15. Cancer Metabolism and the Evasion of Apoptotic Cell Death.
Sharma A; Boise LH; Shanmugam M
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31405035
[TBL] [Abstract][Full Text] [Related]
16. Overcoming drug resistance by targeting protein homeostasis in multiple myeloma.
Moscvin M; Ho M; Bianchi G
Cancer Drug Resist; 2021; 4(4):1028-1046. PubMed ID: 35265794
[TBL] [Abstract][Full Text] [Related]
17. Mitochondria and energetic depression in cell pathophysiology.
Seppet E; Gruno M; Peetsalu A; Gizatullina Z; Nguyen HP; Vielhaber S; Wussling MHP; Trumbeckaite S; Arandarcikaite O; Jerzembeck D; Sonnabend M; Jegorov K; Zierz S; Striggow F; Gellerich FN
Int J Mol Sci; 2009 May; 10(5):2252-2303. PubMed ID: 19564950
[TBL] [Abstract][Full Text] [Related]
18. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer.
Li C; Zhang G; Zhao L; Ma Z; Chen H
World J Surg Oncol; 2016 Jan; 14(1):15. PubMed ID: 26791262
[TBL] [Abstract][Full Text] [Related]
19. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
[TBL] [Abstract][Full Text] [Related]
20. Targeting mitochondria in cancer: current concepts and immunotherapy approaches.
Pustylnikov S; Costabile F; Beghi S; Facciabene A
Transl Res; 2018 Dec; 202():35-51. PubMed ID: 30144423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
